Table 2.
pg/mL | μM | ||||
---|---|---|---|---|---|
IL-4 | IL-10 | IL-12 | IFN-γ | NO | |
Con A | 979.69 ± 3.79 | 590.30 ± 77.20 | 32.16 ± 5,21 | 872.33 ± 17.12 | 7.78 ± 3.49 |
PLA | 37.82 ± 5.67 | 188.30 ± 34.88 | 12.02 ± 11,77 | 474.92 ± 92.24 | 0.84 ± 0.13 |
P1 | ND | ND | 75.00 ± 34.65 | ND | ND |
P2 | ND | ND | ND | 15.88 ± 3.19 | ND |
P4 | ND | 10.97 ± 2.47 | ND | 49.25 ± 20.10 | ND |
P5 | ND | ND | ND | ND | ND |
P6 | ND | 2.97 ± 0.82 | ND | ND | ND |
P7 | ND | ND | ND | ND | ND |
P8 | ND | ND | ND | ND | ND |
Results presented are from a representative assay from three independent repeats using lymph nodes from 15 infected mice. Results are presented as mean ± standard deviation values. ND - below the threshold established by control group.